Published in Arch Ophthalmol on September 01, 1993
Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. ScientificWorldJournal (2012) 1.40
The initial fetal human retinal vasculature develops by vasculogenesis. Dev Dyn (2006) 1.28
Retinal and optic nerve head pathology in Susac's syndrome. Ophthalmology (2011) 1.02
Angiogenic factors in human proliferative sickle cell retinopathy. Br J Ophthalmol (1999) 1.00
Phosphatase enzyme histochemistry for studying vascular hierarchy, pathology, and endothelial cell dysfunction in retina and choroid. Vision Res (2005) 0.90
New classification of peripheral retinal vascular changes in sickle cell disease. Br J Ophthalmol (1994) 0.88
Retinal and choroidal neovascularization in a transgenic mouse model of sickle cell disease. Am J Pathol (1994) 0.87
Neutrophils and leucocyte adhesion molecules in sickle cell retinopathy. Br J Ophthalmol (2002) 0.86
Expression Pattern of HIF-1α and VEGF Supports Circumferential Application of Scatter Laser for Proliferative Sickle Retinopathy. Invest Ophthalmol Vis Sci (2016) 0.78
Possibility of enhanced risk of retinal neovascularization in repeated blood donors: blood donation and retinal alteration. Int J Gen Med (2011) 0.75
Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy. PLoS One (2017) 0.75
Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol (1995) 2.87
High-resolution histologic analysis of the human choroidal vasculature. Invest Ophthalmol Vis Sci (1994) 2.64
Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci U S A (1988) 2.34
Sickle-cell hemoglobin and its relation to fundus abnormality. Arch Ophthalmol (1966) 2.26
Natural history of untreated proliferative sickle retinopathy. Arch Ophthalmol (1971) 2.08
Retinal hypoxia in long-term diabetic cats. Invest Ophthalmol Vis Sci (1998) 1.77
Classification and pathogenesis of proliferative sickle retinopathy. Am J Ophthalmol (1971) 1.67
Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. Invest Ophthalmol Vis Sci (1999) 1.67
Laser-induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion. Arch Ophthalmol (1998) 1.65
Choriocapillaris degeneration and related pathologic changes in human diabetic eyes. Arch Ophthalmol (1998) 1.64
Proliferative retinopathy in sickle cell trait. Report of seven cases. Arch Intern Med (1977) 1.56
Limbal palisades of Vogt. Trans Am Ophthalmol Soc (1982) 1.56
Application of rapid scanning retinal thickness analysis in retinal diseases. Ophthalmology (1997) 1.54
Pilot trial of transscleral diode laser retinopexy in retinal detachment surgery. Arch Ophthalmol (1993) 1.53
Aqueous humor lactic acid dehydrogenase in retinoblastoma. Am J Ophthalmol (1974) 1.50
Macular and perimacular vascular remodelling sickling haemoglobinopathies. Br J Ophthalmol (1976) 1.48
Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. Invest Ophthalmol Vis Sci (1997) 1.46
Retinal arterial macroaneurysms: risk factors and natural history. Br J Ophthalmol (1990) 1.46
Corneal dystrophies of epithelial genesis: the possible therapeutic use of limbal stem cell transplantation. Arch Ophthalmol (2001) 1.44
Elevated intraocular pressure, pigment dispersion and dark hypopyon in endogenous endophthalmitis from Listeria monocytogenes. Surv Ophthalmol (1992) 1.41
Histopathology and ultrastructure of the argon laser lesion in human retinal and choroidal vasculatures. Am J Ophthalmol (1973) 1.40
Immunolocalization of TGF-beta 1, TGF-beta 2, and TGF-beta 3 in the anterior segment of the human eye. Invest Ophthalmol Vis Sci (1993) 1.40
Progressive hemifacial atrophy (Parry-Romberg disease). J Pediatr Ophthalmol Strabismus (1987) 1.38
Ultrastructural ocular pathology of Hunter's syndrome. Systemic mucopolysaccharidosis type II. Arch Ophthalmol (1971) 1.37
Determination of the mechanism of free radical generation in human aortic endothelial cells exposed to anoxia and reoxygenation. J Biol Chem (1994) 1.35
Diagnostic features of the Favre-Goldmann syndrome. Br J Ophthalmol (1976) 1.34
Management of cataract in patients undergoing vitrectomy. Am J Ophthalmol (1975) 1.32
Senescence-associated beta-galactosidase histochemistry for the primate eye. Invest Ophthalmol Vis Sci (1999) 1.32
Argon laser photocoagulation of proliferative sickle retinopathy. Arch Ophthalmol (1973) 1.32
X-linked colobomatous microphthalmos and other congenital anomalies. A disorder resembling Lenz's dysmorphogenetic syndrome. Am J Ophthalmol (1971) 1.30
Peripapillary and macular vessel occlusions in sickle cell anemia. Am J Ophthalmol (1973) 1.30
Spontaneous remodeling of the peripheral retinal vasculature in sickling disorders. Am J Ophthalmol (1975) 1.26
Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med (1998) 1.25
Ophthalmologic manifestations of sickle cell thalassemia. Arch Intern Med (1971) 1.22
Surgery of congenital and juvenile cataracts: a pars plicata approach with the vitrophage. Br J Ophthalmol (1978) 1.21
Sickling hemoglobinopathies; macular and perimacular vascular abnormalities. Arch Ophthalmol (1974) 1.20
Cytopathologic and histopathologic aspects of Fuchs' heterochromic iridocyclitis. Arch Ophthalmol (1965) 1.20
Choroido-vitreal neovascularization after argon laser photocoagulation. Arch Ophthalmol (1975) 1.20
Retinal macroaneurysms. Arch Ophthalmol (1977) 1.19
Vaso-obliteration in the canine model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci (1996) 1.15
Intrachoroidal microvascular abnormality: a previously unrecognized form of choroidal neovascularization. Am J Ophthalmol (1997) 1.15
Traumatic hyphema in children: risk factors for complications. Arch Ophthalmol (2001) 1.15
Choroidal infarction, anterior ischemic optic neuropathy, and central retinal artery occlusion from polyarteritis nodosa. Retina (2001) 1.15
Management of subluxated and dislocated lenses with the vitrophage. Br J Ophthalmol (1979) 1.14
The angiographic pattern of the peripheral retinal vasculature. Arch Ophthalmol (1979) 1.14
Anterior segment ischemia following scleral buckling in sickle cell hemoglobinopathy. Am J Ophthalmol (1971) 1.14
T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci (1998) 1.13
Histopathology of sickle cell retinopathy. Trans Am Acad Ophthalmol Otolaryngol (1974) 1.11
Spontaneous regression (autoinfarction) of proliferative sickle retinopathy. Am J Ophthalmol (1975) 1.10
Ocular histopathology in Hunter's syndrome. Systemic mucopolysaccharidosis type II. Arch Ophthalmol (1967) 1.10
Waardenburg's syndrome with fundus and other anomalies. Arch Ophthalmol (1966) 1.09
Altered distribution of basic fibroblast growth factor in diabetic retinopathy. Arch Ophthalmol (1991) 1.09
Treatment of proliferative sickle retinopathy. Trans Am Acad Ophthalmol Otolaryngol (1971) 1.08
Nanophthalmic sclera. Morphologic and tissue culture studies. Ophthalmology (1986) 1.07
Cytological diagnosis of phacolytic glaucoma utilizing millipore filtration of the aqueous. Br J Ophthalmol (1967) 1.06
Chorioretinal and choriovitreal neovascularization. Their presence after photocoagulation of proliferative sickle cell retinopathy. Arch Ophthalmol (1981) 1.06
Iris transillumination and variable expression in ectopia lentis et pupillae. Am J Ophthalmol (1977) 1.06
Peripheral retinal neovascularization in sarcoidosis. Arch Ophthalmol (1975) 1.06
Evolution of neovascularization in sickle cell retinopathy. A prospective fluorescein angiographic study. Arch Ophthalmol (1977) 1.05
Autosomal dominant vitreoretinochoroidopathy. Arch Ophthalmol (1982) 1.05
Ophthalmologic studies of familial dysautonomia. The Riley-Day syndrome. Arch Ophthalmol (1968) 1.04
Idiopathic sclerochoroidal calcification. Case report. Arch Ophthalmol (1989) 1.04
Acute complications of argon laser photocoagulation. Epipapillary and peripapillary neovascularization. Arch Ophthalmol (1973) 1.03
Evolution of the retinal black sunburst in sickling haemoglobinopathies. Br J Ophthalmol (1975) 1.03
Editorial: Macular ischemia and infarction in sickling. Invest Ophthalmol (1973) 1.03
One hundred consecutive pars plana vitrectomies using the vitrophage. Am J Ophthalmol (1976) 1.03
Clinical and histopathologic features of canine oxygen-induced proliferative retinopathy. Invest Ophthalmol Vis Sci (1998) 1.03
Intracranial assessment of incontinentia pigmenti using magnetic resonance imaging, angiography, and spectroscopic imaging. Arch Pediatr Adolesc Med (1995) 1.03
Bilateral bicolored irides with Hirschsprung's disease. A neural crest syndrome. Arch Ophthalmol (1983) 1.02
Nanophthalmic sclera. Fibronectin studies. Ophthalmology (1988) 1.02
Vasoproliferation in the neonatal dog model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci (1996) 1.02
Aminocaproic acid decreases secondary hemorrhage after traumatic hyphema. Arch Ophthalmol (1983) 1.02
Localization of basic fibroblast growth factor to the developing capillaries of the bovine retina. J Cell Physiol (1989) 1.01
Immediate fundus complications after retinal scatter photocoagulation. I. Clinical picture and pathogenesis. Ophthalmic Surg (1976) 1.01
Vitrectomy and intravitreal antiviral drug therapy in acute retinal necrosis syndrome. Report of two cases. Arch Ophthalmol (1984) 1.01
Familial iris melanosis--a misnomer? Br J Ophthalmol (1989) 1.01
Retinal vaso-occlusion in sickling hemoglobinopathies. Birth Defects Orig Artic Ser (1976) 1.01
Ocular manifestations of sickle hemoglobinopathies. Surv Ophthalmol (1977) 1.01
Cryotherapy of proliferative sickle retinopathy. Part I. Single freeze-thaw cycle. Ann Ophthalmol (1975) 1.01
Four hundred consecutive pars plana vitrectomies with the vitrophage. Arch Ophthalmol (1978) 1.01
Evulsion of the optic nerve in association with basketball injuries. Ann Ophthalmol (1984) 1.00
The systemic mucopolysaccharidoses. Ultrastructural and histochemical studies of conjunctiva and skin. Am J Ophthalmol (1972) 1.00
Angiogenic factors in human proliferative sickle cell retinopathy. Br J Ophthalmol (1999) 1.00
Vitrectomy in 125 eyes with diabetic vitreous haemorrhage. Br J Ophthalmol (1976) 0.99
Occlusive retinal arteriolitis with neovascularization. Am J Ophthalmol (1976) 0.99
Solar maculopathy in a young child. Br J Ophthalmol (2009) 0.99
Measurement and characterization of free radical generation in reoxygenated human endothelial cells. Am J Physiol (1994) 0.99
Developmental abnormalities in the Nuc1 rat retina: a spontaneous mutation that affects neuronal and vascular remodeling and retinal function. Neuroscience (2005) 0.98
Redefining papillorenal syndrome: an underdiagnosed cause of ocular and renal morbidity. Ophthalmology (2001) 0.98
Early detection of retinal involvement in diabetes by vitreous fluorophotometry. Ophthalmology (1979) 0.98
Retinal damage from a Q-switched YAG laser. Am J Ophthalmol (1983) 0.98
Visualization of a developing vasculature. Microvasc Res (1987) 0.98
Hemoglobin SC disease and iris atrophy. Am J Ophthalmol (1973) 0.97
Impaired expression of thrombospondin-1 in eyes with age related macular degeneration. Br J Ophthalmol (2006) 0.97
Macular cherry-red spot, corneal clouding, and beta-galactosidase deficiency. Clinical, biochemical, and electron microscopic study of a new autosomal recessive storage disease. Arch Intern Med (1971) 0.97
Prenatal chromosomal diagnosis. Racial and geographic variation for older women in Georgia. JAMA (1980) 0.96
Experimental argon laser photocoagulation. II. Effects on the optic disc. Arch Ophthalmol (1976) 0.96
Resection of uveal melanocytoma: clinicopathological correlation. Br J Ophthalmol (1983) 0.96
The acute intravenous toxicity of biological stains, dyes, and other fluorescent substances. Toxicol Appl Pharmacol (1978) 0.96
Presence of endothelial cell growth factor activity in normal and diabetic eyes. Curr Eye Res (1986) 0.96